INPST:EURONEXT AMSTERDAMInPost S.A. Analysis
Data as of 2026-06-01 - not real-time
€15.36
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading in a bullish environment with short‑term moving averages comfortably above longer‑term averages and a MACD that remains in bullish territory. However, the RSI is at an extreme level, signalling that the price may be overbought as it hovers just below a clear resistance zone and near its 52‑week high.
Fundamental backdrop: Revenue is expanding at a robust pace and free cash flow remains healthy, while profitability margins are modest. Valuation is stretched, with the price‑earnings multiple far above the industry average and no dividend payout to offset the premium. The company benefits from a very low beta and modest 30‑day volatility, but trading volumes are thin, suggesting liquidity could become a concern if sentiment shifts.
Fundamental backdrop: Revenue is expanding at a robust pace and free cash flow remains healthy, while profitability margins are modest. Valuation is stretched, with the price‑earnings multiple far above the industry average and no dividend payout to offset the premium. The company benefits from a very low beta and modest 30‑day volatility, but trading volumes are thin, suggesting liquidity could become a concern if sentiment shifts.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI at extreme levels indicating potential short‑term pullback
- Price positioned near immediate resistance
- Valuation premium may limit upside
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained revenue growth and solid free cash flow
- Low beta and modest volatility support stability
- High valuation relative to peers could temper returns
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Expanding parcel‑locker network driving growth opportunities
- Strong return on equity and asset efficiency
- Low systematic risk and industry tailwinds in e‑commerce logistics
Key Metrics & Analysis
Financial Health
Revenue Growth30.80%
Profit Margin3.09%
P/E Ratio66.8
ROE15.09%
ROA5.69%
Debt/Equity322.43
P/B Ratio2.5
Free Cash Flow€949.5M
Industry P/E29.9
Technical Analysis
TrendBullish
RSI94.2
Support€15.23
Resistance€15.36
MA 20€15.26
MA 50€15.14
MA 200€12.79
MACDBullish
VolumeStable
Fear & Greed Index93.21
Valuation
Fair Value€68.70
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.13
Volatility4.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.